The FDA has resolved Eli Lilly's tirzepatide shortage, but localized supply issues persist. Meanwhile, Hims & Hers Health's ...
The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 ...
S hares of Hims & Hers (NYSE: HIMS) fell as much as 15% on Thursday after news that Eli Lilly's (NYSE: LLY) GLP-1 drug was taken off the shortage list by the FDA. This could impac ...
The company has been doing incredibly well, and revenue as well as profits have skyrocketed in recent quarters. Shares of ...
Zacks.com on MSN9h
Company News for Oct 4, 2024Levi Strauss & Co.’s (LEVI) shares plunged 7.7% after reporting third-quarter fiscal 2024 net revenues of $1,517 million, missing the Zacks Consensus Estimate of $1,552 million. Shares of ...
Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filing in the gaps.
Blasts Shake Beirut as Israel Targets Hezbollah Leaders, Officials Say Israeli officials said planes bombed a bunker where senior Hezbollah officials were meeting, including the presumed successor ...
Oct. 1, 2024 — The genetic confirmation of a suspected diagnosis of 'hereditary colorectal cancer' is of great importance for the medical care of affected families. However, many of the variants ...
The decision would reopen ports on the East and Gulf Coasts, easing worries that the strike would burden the economy five weeks before the election. 5 min read 3 Ex-Officers Acquitted of Most ...
India will join the 6th round of Moscow Format talks on Afghanistan, with a focus on regional security and counter-terrorism. The talks, attended by Central Asian countries and key players like ...
Vice President Kamala Harris has gone 75 days as the presumptive, and now, official Democratic nominee for president without holding an official press conference. Trump held his third news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback